Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Injury × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 17 Breast Neoplasms 12 Brain Neoplasms 10 Agnosia 7 Neoplasms 6 Thyroid Neoplasms 4 Stomach Neoplasms 4 Delirium 4 Pituitary Neoplasms 3 Lung Neoplasms 3 Emergence Delirium 3 Chronic Pain 3 Urinary Bladder Neoplasms 2 Supratentorial Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pheochromocytoma 2 Pain, Intractable 2 Pain 2 Liver Neoplasms 2 Inflammation 2 Dexmedetomidine 2 Colorectal Neoplasms 2 Central Nervous System Diseases 2 Abdominal Neoplasms 2 Thrombosis 1 Spinal Cord Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Sleep Deprivation 1 Sigmoid Neoplasms 1

Interventions

Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Sodium Chloride 1 Saline Solution 1 Polypropylenes 1 Polyglactin 910 1 Etanercept 1 Drug Delivery Systems 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07385898 2026-02-04

Dex

The Second Affiliated Hospital of Chongqing Medical University

Phase NA Completed

Gastrointestinal

Rectal Neoplasms, Sigmoid Neoplasms, Lung Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡